These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 37612107)

  • 1. Characterising meaningful patient and public involvement in the pharmaceutical industry research setting: a retrospective quality assessment.
    Dews SA; Bassi A; Buckland S; Clements L; Daley R; Davies A; Evett S; Howland S; Kinloch E; Phillips B; Powell G; Preston J; Sterniczuk K; Bohm N
    BMJ Open; 2023 Aug; 13(8):e071339. PubMed ID: 37612107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A proposal to embed patient and public involvement within qualitative data collection and analysis phases of a primary care based implementation study.
    Moult A; McGrath C; Lippiett K; Coope C; Chilcott S; Mann C; Evans N; Turner A; Dziedzic K; Portillo MC; Johnson R
    Res Involv Engagem; 2023 May; 9(1):37. PubMed ID: 37259130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What do pharmaceutical industry professionals in Europe believe about involving patients and the public in research and development of medicines? A qualitative interview study.
    Parsons S; Starling B; Mullan-Jensen C; Tham SG; Warner K; Wever K
    BMJ Open; 2016 Jan; 6(1):e008928. PubMed ID: 26743701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The extent, quality and impact of patient and public involvement in primary care research: a mixed methods study.
    Blackburn S; McLachlan S; Jowett S; Kinghorn P; Gill P; Higginbottom A; Rhodes C; Stevenson F; Jinks C
    Res Involv Engagem; 2018; 4():16. PubMed ID: 29850029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patients as research partners in preference studies: learnings from IMI-PREFER.
    Smith MY; Janssens R; Jimenez-Moreno AC; Cleemput I; Muller M; Oliveri S; Simons G; Strammiello V; Huys I; Falahee M
    Res Involv Engagem; 2023 Apr; 9(1):21. PubMed ID: 37029449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involving the public in mental health and learning disability research: Can we, should we, do we?
    Paul C; Holt J
    J Psychiatr Ment Health Nurs; 2017 Oct; 24(8):570-579. PubMed ID: 28556251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regional working in the East of England: using the UK National Standards for Public Involvement.
    Mathie E; Wythe H; Munday D; Rhodes G; Vicary P; Millac P; Jones J
    Res Involv Engagem; 2018; 4():48. PubMed ID: 30546917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Learning to work together - lessons from a reflective analysis of a research project on public involvement.
    Howe A; Mathie E; Munday D; Cowe M; Goodman C; Keenan J; Kendall S; Poland F; Staniszewska S; Wilson P
    Res Involv Engagem; 2017; 3():1. PubMed ID: 29062526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Procedures and methods of benefit assessments for medicines in Germany].
    Bekkering GE; Kleijnen J
    Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 7():S225-46. PubMed ID: 19034813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and formative evaluation of patient research partner involvement in a multi-disciplinary European translational research project.
    Birch R; Simons G; Wähämaa H; McGrath CM; Johansson EC; Skingle D; Bayliss K; Starling B; Gerlag DM; Buckley CD; Stack RJ; Raza K; Falahee M
    Res Involv Engagem; 2020; 6():6. PubMed ID: 32099665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Developing catalyst films of health experiences: an analysis of a robust multi-stakeholder involvement journey.
    Davis S; Pandhi N; Warren B; Grevious N; Crowder M; Ingersoll H; Perry E; Sussman A; Grob R
    Res Involv Engagem; 2022 Jul; 8(1):34. PubMed ID: 35906697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EUPATI Guidance for Patient Involvement in Medicines Research and Development (R&D); Guidance for Pharmaceutical Industry-Led Medicines R&D.
    Warner K; See W; Haerry D; Klingmann I; Hunter A; May M
    Front Med (Lausanne); 2018; 5():270. PubMed ID: 30356834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Working with public contributors in Parkinson's research: What were the changes, benefits and learnings? A critical reflection from the researcher and public contributor perspective.
    Lithander FE; Tenison E; Jones DA; Stocker S; Hopewell-Kelly N; Gibson A; McGrath C
    Health Expect; 2023 Nov; 27(1):. PubMed ID: 37990485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The benefits, challenges, and best practice for patient and public involvement in evidence synthesis: A systematic review and thematic synthesis.
    Agyei-Manu E; Atkins N; Lee B; Rostron J; Dozier M; Smith M; McQuillan R
    Health Expect; 2023 Aug; 26(4):1436-1452. PubMed ID: 37260191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Co-creation of practical "how-to guides" for patient engagement in key phases of medicines development-from theory to implementation.
    Feldman D; Kruger P; Delbecque L; Duenas A; Bernard-Poenaru O; Wollenschneider S; Hicks N; Reed JA; Sargeant I; Pakarinen C; Hamoir AM; ; ;
    Res Involv Engagem; 2021 Aug; 7(1):57. PubMed ID: 34425911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient and public involvement in research: the need for budgeting PPI staff costs in funding applications.
    De Simoni A; Jackson T; Inglis Humphrey W; Preston J; Mah H; Wood HE; Kinley E; Gonzalez Rienda L; Porteous C
    Res Involv Engagem; 2023 Mar; 9(1):16. PubMed ID: 36966346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient and public involvement of young people with a chronic condition: lessons learned and practical tips from a large participatory program.
    van Schelven F; van der Meulen E; Kroeze N; Ketelaar M; Boeije H
    Res Involv Engagem; 2020; 6():59. PubMed ID: 33005440
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.